SCHEMBL13622855

SCHEMBL13622855

CCC(COCC(O)CN1C(=O)C=CC1=O)(COCC(O)CN1C(=O)C=CC1=O)COCC(O)CN1C(=O)C=CC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.40
MGLL Q99685 4/20 0.36
ALDH1A1 P00352 3/20 0.36
BLM P54132 2/20 0.36
LMNA P02545 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GMNN O75496 1/20 0.36
MAPT P10636 1/20 0.36
THPO P40225 1/20 0.36
PMP22 Q01453 1/20 0.36
KMT2A Q03164 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
WRN Q14191 1/20 0.36
HIF1A Q16665 1/20 0.36
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13622856 0.93 MAPK1 (0.35) MAPK1MGLLALDH1A1BLMLMNA
SCHEMBL13622829 0.87 MGLL (0.35) MAPK1MGLLALDH1A1BLMLMNA
SCHEMBL11994263 0.79 MGLL (0.48) MAPK1MGLLALDH1A1BLMLMNA
SCHEMBL13622832 0.77
SCHEMBL13622827 0.76 MGLL (0.39) MAPK1MGLLALDH1A1BLMLMNA
SCHEMBL16301155 0.75 KMT2A (0.41) MAPK1MGLLALDH1A1BLMLMNA
SCHEMBL13622825 0.74 MAPK1 (0.38) MAPK1MGLLALDH1A1BLMLMNA
SCHEMBL16708707 0.74 ALDH1A1 (0.41) MAPK1MGLLALDH1A1BLMLMNA
SCHEMBL13622830 0.74 MGLL (0.34) MGLLALDH1A1BLMLMNANPSR1
SCHEMBL13622828 0.74 MGLL (0.34) MGLLALDH1A1BLMLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286001-A1 ACTIVE-ENERGY RADIATION-POLYMERIZABLE SUBSTANCE, ACTIVE-ENERGY RADIATION-CURABLE LIQUID COMPOSITION, ACTIVE-ENERGY RADIATION-CURABLE INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286001-A1 ACTIVE-ENERGY RADIATION-POLYMERIZABLE SUBSTANCE, ACTIVE-ENERGY RADIATION-CURABLE LIQUID COMPOSITION, ACTIVE-ENERGY RADIATION-CURABLE INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT, AND INK JET RECORDING APPARATUS DACH1, MMP1, IDUA MAPK1 649/4885MGLL 3871/4885ALDH1A1 591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.